Ghent, Belgium - 3 November 2021 - Sequana Medical NV (Euronext Brussels: SEQUA, the "Company"), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant
Investegate announcements from Sequana Medical NV, Sequana Medical receives MDSAP certification and expands its Quality Management System towards North America